blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1876445

EP1876445 - ANTIBODY DIRECTED AGAINST GASTRIN-RELEASING PEPTIDE PRECURSOR AND USE THEREOF [Right-click to bookmark this link]
StatusOpposition rejected
Status updated on  04.04.2014
Database last updated on 15.06.2024
Most recent event   Tooltip18.07.2014Lapse of the patent in a contracting state
New state(s): HU		published on 20.08.2014  [2014/34]
Applicant(s)For all designated states
Advanced Life Science Institute, Inc.
2-10-23, Maruyamadai
Wako-shi, Saitama, 351-0112 / JP
[2008/02]
Inventor(s)01 / AOYAGI, Katsumi, c/o Advanced Life Science Inst., Inc.
2-10-23 Maruyamadai
Wako-shi, Saitama 3510112 / JP
 [2008/02]
Representative(s)Hiebl, Inge Elisabeth, et al
Kraus & Weisert
Patentanwälte PartGmbB
Thomas-Wimmer-Ring 15
80539 München / DE
[N/P]
Former [2008/02]Hiebl, Inge Elisabeth, et al
Kraus & Weisert Patent- und Rechtsanwälte Thomas-Wimmer-Ring 15
80539 München / DE
Application number, filing date06731744.613.04.2006
[2008/02]
WO2006JP307808
Priority number, dateJP2005011578213.04.2005         Original published format: JP 2005115782
[2008/02]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2006117994
Date:09.11.2006
Language:JA
[2006/45]
Type: A1 Application with search report 
No.:EP1876445
Date:09.01.2008
Language:EN
[2008/02]
Type: B1 Patent specification 
No.:EP1876445
Date:01.06.2011
Language:EN
[2011/22]
Search report(s)International search report - published on:JP09.11.2006
(Supplementary) European search report - dispatched on:EP17.02.2009
ClassificationIPC:G01N33/53, C07K16/26, C12N5/10, C12N15/02
[2008/02]
CPC:
G01N33/57423 (EP,US); G01N33/53 (KR); C07K14/57572 (EP,US);
C07K16/26 (EP,KR,US); C12N15/02 (KR); C12N5/10 (KR);
C07K2317/34 (EP,US); G01N2333/5758 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/02]
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
YUNot yet paid
TitleGerman:GEGEN GASTRIN-RELEASING-PEPTIDE-VORLÄUFER GERICHTETER ANTIKÖRPER[2008/02]
English:ANTIBODY DIRECTED AGAINST GASTRIN-RELEASING PEPTIDE PRECURSOR AND USE THEREOF[2008/02]
French:ANTICORPS DIRIGÉ CONTRE LE PRÉCURSEUR DU PEPTIDE LIBÉRANT LA GASTRINE ET SON UTILISATION[2008/02]
Biological materialThis application mentions deposited biological material, check the file for details
Entry into regional phase02.11.2007Translation filed 
02.11.2007National basic fee paid 
02.11.2007Search fee paid 
02.11.2007Designation fee(s) paid 
02.11.2007Examination fee paid 
Examination procedure02.11.2007Amendment by applicant (claims and/or description)
02.11.2007Examination requested  [2008/02]
25.06.2009Despatch of a communication from the examining division (Time limit: M04)
27.10.2009Reply to a communication from the examining division
03.12.2010Communication of intention to grant the patent
28.03.2011Fee for grant paid
28.03.2011Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  25.06.2009
Opposition(s)Opponent(s)01  01.03.2012  05.04.2012  ADMISSIBLE
Radium Hospital
Oslo University Hospital
Department of Medical Biochemistry
Montebello
0310 Oslo / NO
Opponent's representative
Egeröd, Lisbeth
Valea AB
Box 1098
405 23 Gothenburg / SE
 [N/P]
Former [2012/15]
Opponent(s)01  01.03.2012   
Radium Hospital
Oslo University Hospital
Department of Medical Biochemistry
Montebello
0310 Oslo / NO
Opponent's representative
Egeröd, Lisbeth
Valea AB Lindholmspiren 5
417 56 Gothenburg / SE
16.04.2012Invitation to proprietor to file observations on the notice of opposition
09.10.2012Reply of patent proprietor to notice(s) of opposition
16.07.2013Cancellation of oral proceeding that was planned for 10.09.2013
10.09.2013Date of oral proceedings
20.12.2013Date of despatch of rejection of opposition
30.12.2013Legal effect of rejection of opposition [2014/19]
Fees paidRenewal fee
11.03.2008Renewal fee patent year 03
16.04.2009Renewal fee patent year 04
17.03.2010Renewal fee patent year 05
08.04.2011Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU13.04.2006
AT01.06.2011
BE01.06.2011
CY01.06.2011
CZ01.06.2011
DK01.06.2011
EE01.06.2011
FI01.06.2011
LT01.06.2011
LV01.06.2011
NL01.06.2011
PL01.06.2011
RO01.06.2011
SI01.06.2011
SK01.06.2011
TR01.06.2011
BG01.09.2011
GR02.09.2011
IS01.10.2011
PT03.10.2011
IE13.04.2012
LU13.04.2012
CH30.04.2012
LI30.04.2012
MC30.04.2012
[2014/34]
Former [2014/27]AT01.06.2011
BE01.06.2011
CY01.06.2011
CZ01.06.2011
DK01.06.2011
EE01.06.2011
FI01.06.2011
LT01.06.2011
LV01.06.2011
NL01.06.2011
PL01.06.2011
RO01.06.2011
SI01.06.2011
SK01.06.2011
TR01.06.2011
BG01.09.2011
GR02.09.2011
IS01.10.2011
PT03.10.2011
IE13.04.2012
LU13.04.2012
CH30.04.2012
LI30.04.2012
MC30.04.2012
Former [2014/21]AT01.06.2011
BE01.06.2011
CY01.06.2011
CZ01.06.2011
DK01.06.2011
EE01.06.2011
FI01.06.2011
LT01.06.2011
LV01.06.2011
NL01.06.2011
PL01.06.2011
RO01.06.2011
SI01.06.2011
SK01.06.2011
TR01.06.2011
BG01.09.2011
GR02.09.2011
IS01.10.2011
PT03.10.2011
IE13.04.2012
CH30.04.2012
LI30.04.2012
MC30.04.2012
Former [2013/29]AT01.06.2011
BE01.06.2011
CY01.06.2011
CZ01.06.2011
DK01.06.2011
EE01.06.2011
FI01.06.2011
LT01.06.2011
LV01.06.2011
NL01.06.2011
PL01.06.2011
RO01.06.2011
SI01.06.2011
SK01.06.2011
BG01.09.2011
GR02.09.2011
IS01.10.2011
PT03.10.2011
IE13.04.2012
CH30.04.2012
LI30.04.2012
MC30.04.2012
Former [2012/11]AT01.06.2011
BE01.06.2011
CY01.06.2011
CZ01.06.2011
EE01.06.2011
FI01.06.2011
LT01.06.2011
LV01.06.2011
NL01.06.2011
PL01.06.2011
RO01.06.2011
SI01.06.2011
SK01.06.2011
GR02.09.2011
IS01.10.2011
PT03.10.2011
Former [2012/10]AT01.06.2011
BE01.06.2011
CY01.06.2011
CZ01.06.2011
EE01.06.2011
FI01.06.2011
LT01.06.2011
LV01.06.2011
NL01.06.2011
RO01.06.2011
SI01.06.2011
SK01.06.2011
GR02.09.2011
IS01.10.2011
PT03.10.2011
Former [2012/09]AT01.06.2011
BE01.06.2011
CY01.06.2011
CZ01.06.2011
EE01.06.2011
FI01.06.2011
LT01.06.2011
LV01.06.2011
NL01.06.2011
SI01.06.2011
GR02.09.2011
IS01.10.2011
PT03.10.2011
Former [2012/08]AT01.06.2011
BE01.06.2011
CY01.06.2011
EE01.06.2011
FI01.06.2011
LT01.06.2011
LV01.06.2011
NL01.06.2011
SI01.06.2011
GR02.09.2011
IS01.10.2011
Former [2012/05]AT01.06.2011
BE01.06.2011
CY01.06.2011
FI01.06.2011
LT01.06.2011
LV01.06.2011
NL01.06.2011
SI01.06.2011
GR02.09.2011
Former [2012/01]AT01.06.2011
CY01.06.2011
FI01.06.2011
LT01.06.2011
LV01.06.2011
NL01.06.2011
SI01.06.2011
GR02.09.2011
Former [2011/52]AT01.06.2011
CY01.06.2011
FI01.06.2011
LT01.06.2011
LV01.06.2011
SI01.06.2011
GR02.09.2011
Former [2011/50]CY01.06.2011
FI01.06.2011
LT01.06.2011
LV01.06.2011
SI01.06.2011
GR02.09.2011
Former [2011/49]CY01.06.2011
FI01.06.2011
LT01.06.2011
GR02.09.2011
Former [2011/48]LT01.06.2011
Documents cited:Search[X]EP0811683  (YAMAGUCHI KEN [JP], et al) [X] 1-11* abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.